关注
Luis Gustavo Perez-Rivas
Luis Gustavo Perez-Rivas
在 med.uni-muenchen.de 的电子邮件经过验证
标题
引用次数
年份
Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours
J Simon, LG Perez-Rivas, Y Zhao, F Chasseloup, H Lasolle, C Cortet, ...
European journal of endocrinology 189 (3), 372-378, 2023
72023
Aggressive pituitary tumors and pituitary carcinomas: from pathology to treatment
P Burman, O Casar-Borota, LG Perez-Rivas, OM Dekkers
The Journal of Clinical Endocrinology & Metabolism 108 (7), 1585-1601, 2023
192023
Intact GR dimerization is critical for restraining plasma ACTH levels during chronic psychosocial stress
D Langgartner, M Koenen, S Kupfer, L Glogger, L Kurz, LG Perez-Rivas, ...
Neurobiology of Stress 24, 100541, 2023
12023
TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome
LG Perez-Rivas, J Simon, A Albani, S Tang, S Roeber, G Assié, ...
Acta Neuropathologica Communications 10 (1), 139, 2022
162022
Improved pasireotide response in USP8 mutant corticotroph tumours in vitro
A Albani, LG Perez-Rivas, S Tang, J Simon, KE Lucia, P Colón-Bolea, ...
Endocrine-Related Cancer 29 (8), 503-511, 2022
152022
TP53 mutations in functional corticotroph tumours: prevalence and clinical relevance
LG Perez-Rivas, J Simon, A Albani, R Rotermund, PR Hermus, ...
Endocrine Abstracts 73, 2021
2021
Expression and putative role of 14–3-3 proteins in corticotroph tumours
S Tang, LG Perez-Rivas, A Albani, R Rotermund, J Flitsch, J Honegger, ...
Endocrine Abstracts 73, 2021
2021
HIF1α is a direct regulator of steroidogenesis in the adrenal gland
D Watts, J Stein, A Meneses, N Bechmann, A Neuwirth, D Kaden, ...
Cellular and Molecular Life Sciences 78, 3577-3590, 2021
202021
Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations
M Reincke, A Albani, G Assie, I Bancos, T Brue, M Buchfelder, O Chabre, ...
European journal of endocrinology 184 (3), P1-P16, 2021
422021
Diagnosis and treatment of parasellar lesions
F Gatto, LG Perez-Rivas, NC Olarescu, P Khandeva, K Chachlaki, ...
Neuroendocrinology 110 (9-10), 728-739, 2020
312020
Evidence for increased SSTR5 expression and improved pasireotide response in USP8 mutant corticotroph tumours
A Albani, LG Perez-Rivas, T Sicheng, M Buchfelder, R Rotermund, ...
Endocrine Abstracts 70, 2020
22020
Driver mutations in USP8 wild-type Cushing’s disease
S Sbiera, LG Perez-Rivas, L Taranets, I Weigand, J Flitsch, E Graf, ...
Neuro-oncology 21 (10), 1273-1283, 2019
872019
Aggressive and malignant prolactinomas
NC Olarescu, LG Perez-Rivas, F Gatto, T Cuny, MA Tichomirowa, ...
Neuroendocrinology 109 (1), 57-69, 2019
322019
Heat shock protein 90 as a prognostic marker and therapeutic target for adrenocortical carcinoma
C Siebert, D Ciato, M Murakami, L Frei-Stuber, LG Perez-Rivas, ...
Frontiers in endocrinology 10, 487, 2019
182019
Correlation between responsiveness to CRH stimulation test in Cushing
A Albani, L Perez-Rivas, M Buchfelder, J Honegger, G Stalla, S Zopp, ...
Endocrine Abstracts 63, 2019
2019
Ubiquitin-specific protease 8 (USP8) potentiates glucocorticoid receptor activity in corticotroph tumour cells
L Perez-Rivas, D Ciato, P Colon-Bolea, M Reincke, M Theodoropoulou
Endocrine Abstracts 63, 2019
2019
Inherited forms of primary hyperaldosteronism: new genes, new phenotypes and proposition of a new classification
LG Perez-Rivas, TA Williams, M Reincke
Experimental and Clinical Endocrinology & Diabetes 127 (02/03), 93-99, 2019
312019
Pathogenesis of cushing disease: an update on the genetics of corticotropinomas
A Albani, LG Perez-Rivas, M Reincke, M Theodoropoulou
Endocrine Practice 24 (10), 907-914, 2018
222018
The USP8 mutational status may predict long‐term remission in patients with Cushing's disease
A Albani, LG Pérez‐Rivas, C Dimopoulou, S Zopp, P Colón‐Bolea, ...
Clinical endocrinology 89 (4), 454-458, 2018
792018
Microrna signature as an indicator of the risk of early recurrence in patients with breast cancer
JL CASTRO, EA CONEJO, LGP Rivas, JJ ARAGONÉS, NR ENTRENA
US Patent 10,059,998, 2018
12018
系统目前无法执行此操作,请稍后再试。
文章 1–20